Emerging Infectious Disease (EID) Research Solutions
The potential for infectious diseases to silently emerge and quickly spread throughout a population must be met with the tools needed to develop rapid diagnostic tests and effective treatments.
Leinco Technologies is committed to providing critical antibodies, antigens, and other reagents with the specificity to accelerate response. We have expanded our product offerings to include patient-derived monoclonal antibodies for Ebola Virus, Marburg, VEEV, hPIV3, and more. Download our updated EID brochure to explore the expanded portfolio.
Pathogen Portfolio at a Glance
- Hemorrhagic Fevers
- Respiratory Viruses
- Arboviruses
- Encephalitis Viruses
- Other Emerging Pathogens
Products Targeting More Than 20 Pathogens
Discover antibodies (monoclonal & polyclonal), confirmed matched pairs, antigens, blocking peptides, and other reagents designed to advance your research.
Featured Infectious Disease Case Studies
Seasonal & Respiratory Pathogens
Rapid lateral flow assays depend on well-matched antibody pairs to deliver the sensitivity and selectivity needed for reliable pathogen detection.
This case study details the screening of Flu A nucleoprotein antibody match pairs from Leinco Technologies for use in sandwich-based lateral flow devices.
Download the data to identify the right pairing for your rapid diagnostic development work.
Screening for Flu A Nucleoprotein Match Pairs for Rapid Lateral Flow Devices
Emerging Infectious Diseases
Selecting the right antibody clone for Mpox research starts with knowing how each one performs under real experimental conditions.
In this case study from Dr. John Connor’s lab at Boston University, three Leinco antibody clones were evaluated head-to-head for their ability to bind and visualize mpox virus in cell culture.
Download the data to inform your reagent selection before your next experiment.
Evaluation of Monkeypox Antibody Clones
High-Priority RNA Pathogens
Accurate pathogen detection in both clinical and resource-limited settings depends on high-sensitivity and high-specificity reagents.
This application note details rapid antibody screening results and performance data for two significant pathogens: Henipavirus (Nipah) and Rotavirus.
Download the report to review the data and inform your diagnostic assay development.
Rapid Antibody Screening Report: New Antibodies For Henipavirus (Nipah) & Rotavirus, Excellent Sensitivity & Specificity
Full Support for Infectious Disease Assay Development
Partner with Leinco for trusted solutions and services that help advance your assay from concept to commercialization.
More Infectious Disease Resources
Seasonal and Respiratory Pathogens Brochure
